Thursday, April 3, 2025
HomeNews

News

Eiger BioPharmaceuticals Strengthens Leadership Team with New Executive Appointments

Eiger BioPharmaceuticals, Inc. a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other...

WithMe Health joins Castlight Health’s ecosystem partner network to help lower spend, improve outcomes, and deliver a better medication experience

WithMe Health , a modern PBM and personalized medication guidance digital health company, has formally joined the Castlight Health ecosystem partners roster. With this ecosystem...

Lumen Bioscience Announces Clinical Advancement of LMN-201 for C. difficile Infection

Lumen Bioscience, a clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases, announced clinical development progress for LMN-201, an investigational orally delivered cocktail...

Argus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc. (TSX:PMN & OTCQB: ARFXF)

Argus Research, an independent investment research firm, has launched Argus Equity Report coverage on ProMIS Neurosciences, Inc. Click here to view Full Argus Equity Report Excerpts...

Phio Pharmaceuticals Selected to Present at the Tumor Immune Microenvironment Workshop of the Society for Immunotherapy of Cancer

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic...
0FansLike
0FollowersFollow
spot_img

Hot Topics